• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks

    Green Growth Brands CEO Peter Horvath: Topicals

    Kevin Vanstone
    Jul. 03, 2019 02:21PM PST
    Cannabis Investing News
    CSE:GGB

    Green Growth Brands (CSE:GGB, OTCQB:GGBXF) CEO Peter Horvath recently joined CNBC’s ‘Mad Money’ to discuss the growing CBD market.

    Green Growth Brands (CSE:GGB, OTCQB:GGBXF) CEO Peter Horvath recently joined CNBC’s ‘Mad Money’ to discuss the growing CBD market.

    During the feature, Horvath spoke with host Jim Cramer regarding the difference between CBD products and traditional cannabis products. The CBD market appears ready for significant growth, with industry experts like CNBC reporting the CBD industry has the potential to become a $22 billion market by 2022. This growth is expected to be driven by companies like Green Growth Brands, who have already opened 60 CBD-focused stores in the United States with another 170 expected to be opened over the next several months.

    According to Horvath, the CBD market currently offers a more significant opportunity as US regulators have chosen to initially focus on the THC marketplace. “We’ve decided only to sell a topical product, which means it doesn’t get into your blood, which means the FDA isn’t as interested in it. People are selling inhalable and ingestible CBD and right now that’s federally illegal, per the FDA. That’s why we focused on topical,” said Horvath.

    The company intends to leverage its experience in retail and personal healthcare products to create a comprehensive line of CBD products that are GMP-certified and fit for national distribution.

    To watch the full interview between Horvath and CNBC’s Jim Cramer, click here.

    Click here to connect with Green Growth Brands (CSE:GGB) for an Investor Presentation. 

    peter horvathcse:ggbgreen growth brands
    The Conversation (0)

    Go Deeper

    AI Powered
    Green Thumb Industries Inc

    Green Thumb Industries Inc

    CSE Marijuana Stocks

    CSE Marijuana Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×